Dr. Gs Clear Nail

Product NDC
60193-101
11-digit product format
601930101
Labeler code
60193
Product ID
60193-101_dde8e58a-8b52-4404-8238-8c22a21c9daf
Type
HUMAN OTC DRUG
Nonproprietary name
TOLNAFTATE
Dosage form
LIQUID
Route
TOPICAL
Labeler
Pacific World Corporation
Application
part333C
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2013-04-24
Marketing end
0000-00-00
Substance
TOLNAFTATE
Active strength
10 mg/mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductIInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage60193-101-02IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductIInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage60193-101-02IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage60193-101-02IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage60193-101-02IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage60193-101-02IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage60193-101-02IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage60193-101-02IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage60193-101-02IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage60193-101-02IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage60193-101-02IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage60193-101-02IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage60193-101-02IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproductIInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage60193-101-02IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproductIInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage60193-101-02IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproductIInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage60193-101-02IInactivated by FDA1332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage60193-101-02IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage60193-101-02IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage60193-101-02IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage60193-101-02IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage60193-101-02IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage60193-101-02IInactivated by FDA9bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproductEExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage60193-101-02EExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60193-101-022020-01-31C16284748780-19d75b9d1-14f7-f424-e053-dadaa90a57ceDr. G's Clear Nail ®

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TOLNAFTATEACTIVE INGREDIENT06KB629TKVDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
TOLNAFTATEACTIVE MOIETY06KB629TKVDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
ALLANTOININACTIVE INGREDIENT344S277G0ZDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
BENZETHONIUM CHLORIDEINACTIVE INGREDIENTPH41D05744DR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
CETRIMONIUM CHLORIDEINACTIVE INGREDIENTUC9PE95IBPDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
COCAMIDOPROPYL BETAINEINACTIVE INGREDIENT5OCF3O11KXDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
COCAMIDOPROPYLAMINE OXIDEINACTIVE INGREDIENTM4SL82J7HKDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
DIDECYLDIMONIUM CHLORIDEINACTIVE INGREDIENTJXN40O9Y9BDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
ISOPROPYL PALMITATEINACTIVE INGREDIENT8CRQ2TH63MDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7UDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE)INACTIVE INGREDIENT255PIF62MSDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
POLYQUATERNIUM-37 (3000 MPA.S)INACTIVE INGREDIENTHU373G0YSUDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
PPG-1 TRIDECETH-6INACTIVE INGREDIENT1K7417JX6QDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
PROPYLENE GLYCOL DICAPRYLATE/DICAPRATEINACTIVE INGREDIENTO4446S9CRADR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
QUATERNIUM-15INACTIVE INGREDIENTE40U03LEM0DR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3
WATERINACTIVE INGREDIENT059QF0KO0RDR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60193-101DR. GS CLEAR NAIL (TOLNAFTATE) LIQUID [PACIFIC WORLD CORPORATION]3Legacy NDC20141021_17861bc1-d560-49a7-90a9-cd978b708a0a.zip